tiprankstipranks
TriSalus Life Sciences (TLSI)
NASDAQ:TLSI
US Market
TLSI
TriSalus Life Sciences
RESEARCH TOOLSreports

TriSalus Life Sciences (TLSI) Income Statement

78 Followers

TriSalus Life Sciences Income Statement

Last quarter (Q4 2025), TriSalus Life Sciences's total revenue was $13.21M, an increase of 59.85% from the same quarter last year. In Q4, TriSalus Life Sciences's net income was $-9.75M. See TriSalus Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Dec 22Dec 21
Total Revenue
$ 45.15M$ 29.43M$ 18.51M$ 12.40M$ 8.40M
Gross Profit
$ 38.19M$ 25.33M$ 15.91M$ 10.14M$ 7.21M
Operating Expenses
$ 65.13M$ 61.49M$ 70.38M$ 46.58M$ 31.24M
Depreciation and Amortization
$ 0.00$ -3.04M$ 684.00K$ 414.00K$ 464.00K
EBITDA
$ -26.95M$ -36.16M$ -58.65M$ -46.76M$ -23.57M
Operating Income
$ -26.95M$ -36.16M$ -54.48M$ -36.44M$ -24.03M
Other Income/Expenses
$ -12.27M$ 6.13M$ -4.88M$ -10.74M$ -4.81M
Pretax Income
$ -39.22M$ -30.04M$ -59.35M$ -47.18M$ -28.84M
Net Income
$ -39.23M$ -33.23M$ -59.36M$ -47.19M$ -28.84M
Per Share Metrics
Basic EPS
$ -1.84$ -1.25$ -2.23$ -1.59$ -0.92
Diluted EPS
$ -1.84$ -1.25$ -2.23$ -1.59$ -0.92
Weighted Average Shares Outstanding
 37.90M 26.50M 26.47M 29.61M 31.25M
Weighted Average Shares Outstanding (Diluted)
 37.90M 26.50M 26.47M 29.61M 31.25M
Currency in USD

TriSalus Life Sciences Earnings and Revenue History